Review article: Externally derived control arms-An opportunity for clinical trials in inflammatory bowel disease?

While this approach has several pitfalls, and is not robust enough to replace traditional randomised, placebo-controlled trials, it may offer a compromise to address key research questions at a more rapid pace, with fewer patients, and lower cost.